Inhibition of osteoclastogenesis by osteoblast-like cells genetically engineered to produce interleukin-10
Inhibition of osteoclastogenesis by osteoblast-like cells genetically engineered to produce interleukin-10
复制标题
DOI:
10.1016/j.bbrc.2014.12.040
复制
发表时间:
2015-01-16
影响因子:
3.1
通讯作者:
Mazda, Osam
中科院分区:
文献类型:
--
作者:
Fujioka, Kazuki;Kishida, Tsunao;Mazda, Osam
Bone destruction at inflamed joints is an important complication associated with rheumatoid arthritis (RA). Interleukin-10 (IL-10) may suppress not only inflammation but also induction of osteoclasts that play key roles in the bone destruction. If IL-10-producing osteoblast-like cells are induced from patient somatic cells and transplanted back into the destructive bone lesion, such therapy may promote bone remodeling by the cooperative effects of IL-10 and osteoblasts. We transduced mouse fibroblasts with genes for IL-10 and Runx2 that is a crucial transcription factor for osteoblast differentiation. The IL-10producing induced osteoblast-like cells (IL-10-iOBs) strongly expressed osteoblast-specific genes and massively produced bone matrix that were mineralized by calcium phosphate in vitro and in vivo. Culture supernatant of IL-10-iOBs significantly suppressed induction of osteoclast from RANKL-stimulated Raw264.7 cells as well as LPS-induced production of inflammatory cytokine by macrophages. The IL10-iOBs may be applicable to novel cell-based therapy against bone destruction associated with RA. (C) 2014 Elsevier Inc. All rights reserved.